Heart Rate Variability Today

Progress in Cardiovascular Diseases

Volumn 55, Issue 3, 2012, Pages 321-331

  Xhyheri, Borejda ^a   Manfrini, Olivia ^a   Mazzolini, Massimiliano ^a   Pizzi, Carmine ^a   Bugiardini, Raffaele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Autonomic nervous system; Coronary circulation; Heart rate variability; Parasympathetic activity

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LIPID; SPIRONOLACTONE;

ACUTE HEART INFARCTION; AFRICAN AMERICAN; AGING; ARTICLE; ATHEROSCLEROSIS; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM FUNCTION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CIRCADIAN RHYTHM; CLINICAL EVALUATION; CLINICAL PRACTICE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DEFIBRILLATION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; ETHNIC DIFFERENCE; EVENT FREE SURVIVAL; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART RATE VARIABILITY; HOLTER MONITORING; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MORTALITY; NON INVASIVE MEASUREMENT; NONHUMAN; POWER SPECTRUM; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; RR INTERVAL; SEX DIFFERENCE; SIDE EFFECT; SMOKING; SUDDEN DEATH;

AUTONOMIC NERVOUS SYSTEM; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR DISEASES; HEART RATE; HUMANS;

EID: 84870482179     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2012.09.001     Document Type: Article

References (121)

1. Bigger J.T., Fleiss J.L., Steinman R.C., et al. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992, 85:164-171.
2. Kleiger R.E., Miller J.P., Bigger J.T., et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987, 59:256-262.
3. Benhorin J., Moss A.J., Oakes D., et al. The prognostic significance of first myocardial infarction type (Q wave versus non-Q wave) and Q wave location. The Multicenter Diltiazem Post-Infarction Research Group. J Am Coll Cardiol 1990, 15:1201-1207.
4. Bigger J.T., Fleiss J.L., Rolnitzky L.M., et al. Time course of recovery of heart period variability after myocardial infarction. J Am Coll Cardiol 1991, 18:1643-1649.
5. Greenberg H., Gillespie J., Dwyer E.M. A new electrocardiographic classification for post-myocardial infarction clinical trials. Am J Cardiol 1987, 59:1057-1063.
6. Bigger J.T., Fleiss J.L., Rolnitzky L.M. Prevalence, characteristics and significance of ventricular tachycardia detected by 24-hour continuous electrocardiographic recordings in the late hospital phase of acute myocardial infarction. Am J Cardiol 1986 Dec 1, 58:1151-1160.
7. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996, 17:354-381. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.
8. Saul J.P., Albrecht P., Berger R.D., et al. Analysis of long-term heart rate variability: Methods, 1/f scaling and implications. Comput Cardiol 1988, 14:419-422.
9. La Rovere M.T., Bigger J.T., Marcus F.I., et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998, 351:478-484.
10. Zuanetti G., Neilson J.M., Latini R., et al. Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico. Circulation 1996, 94:432-436.
11. Bernardi L., Wdowczyk-Szulc J., Valenti C., et al. Effects of controlled breathing, mental activity and mental stress with or without verbalization on heart rate variability. J Am Coll Cardiol 2000, 35:1462-1469.
12. Ewing D.J., Neilson J.M., Shapiro C.M., et al. Twenty four hour heart rate variability: effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients. Br Heart J 1991, 65:239-244.
13. Goldsmith R.L., Bigger J.T., Steinman R.C., et al. Comparison of 24-hour parasympathetic activity in endurance-trained and untrained young men. J Am Coll Cardiol 1992, 20:552-558.
14. Hautala A.J., Mäkikallio T.H., Kiviniemi A., et al. Cardiovascular autonomic function correlates with the response to aerobic training in healthy sedentary subjects. Am J Physiol Heart Circ Physiol 2003, 285:1747-1752.
15. Li X., Shaffer M.L., Rodriguez-Colon S., et al. The circadian pattern of cardiac autonomic modulation in a middle-aged population. Clin Auton Res 2011, 21:143-150.
16. Bigger J.T., Fleiss J.L., Steinman R.C., et al. Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction. Am J Cardiol 1992, 69:891-898.
17. Pomeranz B., Macaulay R.J., Caudill M.A., et al. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985, 248:151-153.
18. Malliani A., Pagani M., Lombardi F., et al. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991, 84:1482-1492.
19. Bonnemeier H., Richardt G., Potratz J., et al. Circadian profile of cardiac autonomic nervous modulation in healthy subjects: differing effects of aging and gender on heart rate variability. J Cardiovasc Electrophysiol 2003, 14:791-799.
20. Reardon M., Malik M. Changes in heart rate variability with age. Pacing Clin Electrophysiol 1996, 19:1863-1866.
21. Zulfiqar U., Jurivich D.A., Gao W., et al. Relation of high heart rate variability to healthy longevity. Am J Cardiol 2010, 105:1181-1185.
22. Stein P.K., Kleiger R.E., Rottman J.N. Differing effects of age on heart rate variability in men and women. Am J Cardiol 1997, 80:302-305.
23. Bugiardini R. Normal coronary arteries: clinical implications and further classification. Herz 2005, 30:3-7.
24. Poon S., Goodman S.G., Yan R.T., et al. Bridging the gender gap: insights from a contemporary analysis of sex-related differences in the treatment and outcomes of patients with acute coronary syndromes. Am Heart J 2012, 163:66-73.
25. Merz C.N., Shaw L.J. Stable angina in women: lessons from the National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. J Cardiovasc Med (Hagerstown) 2011, 12:85-87.
26. Vaccarino V., Badimon L., Corti R., et al. Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. Cardiovasc Res 2011, 90:9-17.
27. Xhyheri B., Bugiardini R. Diagnosis and treatment of heart disease: are women different from men?. Prog Cardiovasc Dis 2010, 53:227-236.
28. Ramaekers D., Ector H., Aubert A.E., et al. Heart rate variability and heart rate in healthy volunteers. Is the female autonomic nervous system cardioprotective?. Eur Heart J 1998, 19:1334-1341.
29. Bugiardini R., Estrada J.L., Nikus K., et al. Gender bias in acute coronary syndromes. Curr Vasc Pharmacol 2010, 8:276-284.
30. Bugiardini R., Yan A.T., Yan R.T., et al. Factors influencing underutilization of evidence-based therapies in women. Eur Heart J 2011, 32:1337-1344.
31. Tatu-Chitoiu G., Cinteza M., Dorobantu M., et al. In-hospital case fatality rates for acute myocardial infarction in Romania. CMAJ 2009, 180:1207-1213.
32. Choi J.B., Hong S., Nelesen R., et al. Age and ethnicity differences in short-term heart-rate variability. Psychosom Med 2006, 68:421-426.
33. Abdel-Wahab M., Khattab A.A., Toelg R., et al. Plaque characteristics of nonobstructive coronary lesions in diabetic patients: an intravascular ultrasound virtual histology analysis. J Cardiovasc Med (Hagerstown) 2010, 11:345-351.
34. Taçoy G., Açikgöz K., Kocaman S.A., et al. Is there a relationship between obesity, heart rate variability and inflammatory parameters in heart failure?. J Cardiovasc Med (Hagerstown) 2010, 11:118-124.
35. Astrup A.S., Tarnow L., Rossing P., et al. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care 2006, 29:334-339.
36. Liao D., Carnethon M., Evans G.W., et al. Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetes 2002, 51:3524-3531.
37. Schroeder E.B., Chambless L.E., Liao D., et al. Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 2005, 28:668-674.
38. Singh J.P., Larson M.G., O'Donnell C.J., et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol 2000, 86:309-312.
39. Vinik A.L., Maser R.E., Mitchell B.D., et al. Diabetic autonomic neuropathy. Diabetes Care 2003, 26:1553-1559.
40. Whang W., Bigger J.T. Comparison of the prognostic value of RR-interval variability after acute myocardial infarction in patients with versus those without diabetes mellitus. Am J Cardiol 2003, 92:247-251.
41. Rathmann W., Ziegler D., Jahnke M., et al. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 1993, 10:820-824.
42. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986. The Diabetes Control and Complications Trial Research Group.
43. Berton G., Cordiano R., Palatini P. Albuminuria during acute myocardial infarction and prognosis: a methodological issue. J Cardiovasc Med (Hagerstown) 2011, 12:376-377.
44. Lazzeri C., Valente S., Chiostri M., et al. Microalbuminuria in hypertensive nondiabetic patients with ST elevation myocardial infarction. J Cardiovasc Med (Hagerstown) 2010, 11:748-753.
45. Tabaei B.P., Al Kassab A.S., Ilag L.L., et al. Does microalbuminuria predict diabetic nephropathy?. Diabetes Care 2001, 24:1560-1566.
46. Ebbehoj E., Poulsen P.L., Hansen K.W., et al. Effects on heart rate variability of metoprolol supplementary to ongoing ACE-inhibitor treatment in type 1 diabetic patients with abnormal albuminuria. Diabetologia 2002, 45:965-975.
47. Kontopoulos A.G., Athyros V.G., Didangelos T.P., et al. Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diabetes Care 1997, 20:355-361.
48. Malik R.A., Williamson S., Abbott C., et al. Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet 1998, 352:1978-1981.
49. Davies J.I., Band M., Morris A., Struthers A.D. Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes. Diabetologia 2004, 47:1687-1694.
50. Bugiardini R. Endothelial function and the prediction of CVD in diabetes. Curr Diab Rep 2006, 6:17-21.
51. Bugiardini R., Manfrini O., Pizzi C., et al. Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation 2004, 109:2518-2523.
52. Pizzi C., Manfrini O., Fontana F., et al. Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac Syndrome X: role of superoxide dismutase activity. Circulation 2004, 109:53-58.
53. Christensen J.H., Toft E., Christensen M.S., et al. Heart rate variability and plasma lipids in men with and without ischaemic heart disease. Atherosclerosis 1999, 145:181-186.
54. Liao D., Sloan R.P., Cascio W.E., et al. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care 1998, 21:2116-2122.
55. Karason K., Mølgaard H., Wikstrand J., et al. Heart rate variability in obesity and the effect of weight loss. Am J Cardiol 1999, 83:1242-1247.
56. Singh J.P., Larson M.G., Tsuji H., et al. Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension 1998, 32:293-297.
57. Schroeder E.B., Liao D., Chambless L.E., et al. Hypertension, blood pressure, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Hypertension 2003, 42:1106-1111.
58. Barutcu I., Esen A.M., Kaya D., et al. Cigarette smoking and heart rate variability: dynamic influence of parasympathetic and sympathetic maneuvers. Ann Noninvasive Electrocardiol 2005, 10:324-329.
59. Kageyama T., Nishikido N., Honda Y., et al. Effects of obesity, current smoking status, and alcohol consumption on heart rate variability in male white-collar workers. Int Arch Occup Environ 1997, 69:447-454.
60. Murata K., Landrigen P.J., Araki S. Effects of heart rate, gender, tobacco and alcohol ingestion on R-R interval variability in human ECG. J Auton Nerv Syst 1991, 37:199-206.
61. Karakaya O., Barutcu I., Kaya D., et al. Acute effect of cigarette smoking on heart rate variability. Angiology 2007, 58:620-624.
62. Manfrini O., Morgagni G., Pizzi C., et al. Changes in autonomic nervous system activity: spontaneous versus balloon induced myocardial ischaemia. Eur Heart J 2004, 25:1502-1508.
63. Quillen J.E., Rossen J.D., Oskarsson H.J., et al. Acute effect of cigarette smoking on the coronary circulation: constriction of epicardial and resistance vessels. J Am Coll Cardiol 1993, 22:642-647.
64. Huikuri H.V., Jokinen V., Syvänne M., et al. Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1999, 19:1979-1985.
65. Kwon D.Y., Lim H.E., Park M.H., et al. Carotid atherosclerosis and heart rate variability in ischemic stroke. Clin Auton Res 2008, 18:355-357.
66. Dekker J.M., Crow R.S., Folsom A.R., et al. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis Risk In Communities. Circulation 2000, 102:1239-1244.
67. Manfrini O., Pizzi C., Viecca M., Bugiardini R. Abnormalities of cardiac autonomic nervous activity correlate with expansive coronary artery remodelling. Atherosclerosis 2008, 197:183-189.
68. Pozzati A., Pancaldi L.G., Di Pasquale G., et al. Transient sympathovagal imbalance triggers "ischemic" sudden death in patients undergoing electrocardiographic Holter monitoring. J Am Coll Cardiol 1996, 27:847-852.
69. Manfrini O., Pizzi C., Trerè D., et al. Parasympathetic failure and risk of subsequent coronary events in unstable angina and non-ST-segment elevation myocardial infarction. Eur Heart J 2003, 24:1560-1566.
70. Di Monaco A., Bruno I., Calcagni M.L., et al. Cardiac adrenergic nerve function in patients with cardiac syndrome X. J Cardiovasc Med (Hagerstown) 2010, 11:151-156.
71. Mølgaard H., Sørensen K.E., Bjerregaard P. Attenuated 24-h heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death. Clin Auton Res 1991, 1:233-237.
72. Valkama J.O., Huikuri H.V., Koistinen M.J., et al. Relation between heart rate variability and spontaneous and induced ventricular arrhythmias in patients with coronary artery disease. J Am Coll Cardiol 1995, 25:437-443.
73. Martin G.J., Magid N.M., Myers G., et al. Heart rate variability and sudden death secondary to coronary artery disease during ambulatory electrocardiographic monitoring. Am J Cardiol 1987, 60:86-89.
74. Camm A.J., Pratt C.M., Schwartz P.J., et al. AzimiLide post Infarct surVival Evaluation (ALIVE) Investigators; Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification. Circulation 2004, 109:990-996.
75. Giammaria M., Bruna C., Gnavi R. Sezione Piemontese of the Associazione Italiana di Aritmologia e Cardiostimolazione. Trend in implantable cardioverter defibrillators and relation to need. J Cardiovasc Med (Hagerstown) 2010, 11:265-270.
76. Hohnloser S.H., Kuck K.H., Dorian P., et al. DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004, 351:2481-2488.
77. Willich S.N., Maclure M., Mittleman M., et al. Sudden cardiac death. Support for a role of triggering in causation. Circulation 1993, 87:1442-1450.
78. Zipes D.P., Wellens H.J.J. Sudden cardiac death. Circulation 1998, 98:2334-2351.
79. Casado M.A., Sevilla M.A., Alonso M.J., et al. Muscarinic receptors involved in modulation of norepinephrine release and vasodilatation in guinea pig carotid arteries. J Pharmacol Exp Ther 1994, 271:1638-1646.
80. Kent K.M., Smith E.R., Redwood D.R., et al. Electrical stability of acutely ischemic myocardium. Influences of heart rate and vagal stimulation. Circulation 1973, 47:291-298.
81. Loffelholz K., Muscholl E. A muscarinic inhibition of the noradrenaline release evoked by postganglionic sympathetic nerve stimulation. Naunyn-Schmiedebergs Arch Pharmakol 1969, 265:1-15.
82. Watanabe A.M., McConnaughey M.M., Strawbridge R.A., et al. Muscarinic cholinergic receptor modulation of beta-adrenoreceptor affinity for catecholamines. J Biol Chem 1978, 253:4833-4836.
83. Communal C., Singh K., Sawyer D.B., et al. Opposing effects of beta (1)- and beta (2)-adrenergic receptors on cardiac myocyte apoptosis. Role of a pertussis-toxin sensitive G protein. Circulation 1999, 100:2210-2212.
84. Mann D.L., Kent R.L., Parsons B., et al. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 1992, 85:790-804.
85. Kovach J.A., Gottdiener J.S., Verrier R.L. Vagal modulation of epicardial coronary artery size in dogs. A two-dimensional intravascular ultrasound study. Circulation 1995, 92:2291-2298.
86. Eshtehardi P., Dhawan S.S., McDaniel M.C., et al. Intravascular imaging findings in severe coronary vasospasm. J Cardiovasc Med (Hagerstown) 2011, 12:578-580.
87. De Ferrari G.M., Leonardi S., Baduena L., et al. Patients with acute coronary syndrome and nonobstructive coronary artery disease in the real world are markedly undertreated. J Cardiovasc Med (Hagerstown) 2011, 12:700-708.
88. Manfrini O., Pizzi C., Morgagni G., et al. Effect of pravastatin on myocardial perfusion after percutaneous transluminal coronary angioplasty. Am J Cardiol 2004, 93:1391-1393.
89. Manfrini O., Slucca M., Pizzi C., et al. Effect of percutaneous coronary intervention on coronary blood flow at rest in myocardial sites remote from the intervention site in patients with stable angina pectoris. Am J Cardiol 2008, 101:776-779.
90. Quyyumi A.A., Dakak N., Mulcahy D., et al. Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol 1997, 29:308-317.
91. Manfrini O., Bugiardini R. Barriers to clinical risk scores adoption. Eur Heart J 2007, 28:1045-1046.
92. Bugiardini R., Badimon L., Collins P., et al. Angina, "normal" coronary angiography, and vascular dysfunction: risk assessment strategies. PLoS Med 2007, 4:e12.
93. Bugiardini R. Women, 'non-specific' chest pain, and normal or near-normal coronary angiograms are not synonymous with favourable outcome. Eur Heart J 2006, 27:1387-1389.
94. Heusch G. The paradox of α-adrenergic coronary vasoconstriction revisited. J Mol Cell Cardiol 2011, 51:16-23.
95. Lin L.Y., Wu C.C., Liu Y.B., et al. Derangement of heart rate variability during a catastrophic earthquake: a possible mechanism for increased heart attacks. Pacing Clin Electrophysiol 2001, 24:1596-1601.
96. Manfrini O., Bazzocchi G., Luati A., et al. Coronary spasm reflects inputs from the adjacent esophageal system. Am J Physiol Heart Circ Physiol 2006, 290:H2085-H2091.
97. Pizzi C., Manzoli L., Mancini S., et al. Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function. Eur Heart J 2008, 29:1110-1117.
98. Fauchier L., Babuty D., Cosnay P., et al. Heart rate variability in idiopathic dilated cardiomyopathy: characteristics and prognostic value. J Am Coll Cardiol 1997, 30:1009-1014.
99. Pizzi C., Manzoli L., Mancini S., et al. Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors. Atherosclerosis 2010, 212:292-298.
100. Kearney M.T., Fox K.A., Lee A.J., et al. Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol 2002, 40:1801-1808.
101. Kienzle M.G., Ferguson D.W., Birkett C.L., et al. Clinical, hemodynamic and sympathetic neural correlates of heart rate variability in congestive heart failure. Am J Cardiol 1992, 69:761-767.
102. Martínez-Sellés M., Martínez E., Cortés M., et al. Determinants of long-term survival in patients hospitalized for heart failure. J Cardiovasc Med (Hagerstown) 2010, 11:164-169.
103. Mortara A., La Rovere M.T., Signorini M.G., et al. Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after transplantation. Br Heart J 1994, 71:422-430.
104. Ponikowski P., Anker S.D., Chua T.P., et al. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1997, 79:1645-1650.
105. Nolan J., Batin P.D., Andrews R., et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart). Circulation 1998, 98:1510-1516.
106. La Rovere M.T., Pinna G.D., Maestri R., et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 2003, 107:565-570.
107. Sandercock G.R., Brodie D.A. The role of heart rate variability in prognosis for different modes of death in chronic heart failure. Pacing Clin Electrophysiol 2006, 29:892-904.
108. Takase B., Kurita A., Noritake M., et al. Heart rate variability in patients with diabetes mellitus, ischaemic heart disease and congestive heart failure. J Electrocardiol 1992, 25:79-88.
109. Goldman S., Johnson G., Cohn J.N., Cintron G., Smith R., Francis G. Mechanism of death in heart failure. The vasodilators-heart failure trials. The V-HeFT VA Cooperative Studies Group. Circulation 1993, 87:124-131.
110. Heusch G., Schulz R. A radical view on the contractile machinery in human heart failure. J Am Coll Cardiol 2011, 18(57):310-312.
111. Forleo G.B., Della Rocca D.G., Papavasileiou L.P., et al. Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction. J Cardiovasc Med (Hagerstown) 2011, 12:779-784.
112. Luu M., Stevenson W.G., Stevenson L.W., et al. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 1989, 80:1675-1680.
113. Piotrowicz K., Noyes K., Lyness J.M., et al. Physical functioning and mental well-being in association with health outcome in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial II. Eur Heart J 2007, 28:601-607.
114. Fantoni C., Raffa S., Regoli F., et al. Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure. J Am Coll Cardiol 2005, 46:1875-1882.
115. Gademan M.G., van Bommel R.J., Ypenburg C., et al. Biventricular pacing in chronic heart failure acutely facilitates the arterial baroreflex. Am J Physiol Heart Circ Physiol 2008, 295:755-760.
116. Santangelo G., Dugo D., Mulè M., et al. Functional and clinical implications of cardiac resynchronization therapy on outcomes of diabetic patients with heart failure. J Cardiovasc Med (Hagerstown) 2011, 12:396-400.
117. Tang W.H., Francis G.S. Cardiac resynchronization therapy in patients with class I-II heart failure and a wide QRS: a cautionary note. Circulation 2011, 123:203-208.
118. Gardini A., Lupo P., Zanelli E., et al. Diagnostic capabilities of devices for cardiac resynchronization therapy. J Cardiovasc Med (Hagerstown) 2010, 11:186-189.
119. Adamson P.B., Smith A.L., Abraham W.T., et al. InSync III Model 8042 and Attain OTW Lead Model 4193 Clinical Trial Investigators. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation 2004, 110:2389-2394.
120. Felber Dietrich D., Schindler C., Schwartz J., et al. Heart rate variability in an ageing population and its association with lifestyle and cardiovascular risk factors: results of the SAPALDIA study. Europace 2006, 8:521-529. SAPALDIA Team.
121. Milicević G., Lakusić N., Szirovicza L., et al. Different cut-off points of decreased heart rate variability for different groups of cardiac patients. J Cardiovasc Risk 2001, 8:93-102.